- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Remdesivir (CAT#: Vinh-Wyb012)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-Wyb012 |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- Molecular Formula: C27H35N6O8P; Molecular Weight: 602.58 g.mol-1
- CAS No.
- 1809249-37-3
- Target
- SARS-CoV-2
- Molecular Formula
- C27H35N6O8P
- Molecular Weight
- 602.58 g.mol-1
- Purity
- >98%
- Introduction
- Remdesivir is a cyano-substituted adenosine nucleotide analog prodrug and shows broad-spectrum antiviral activity against several RNA viruses. In HAE cells, Remdesivir has an EC50 value of 74 nM for SARS-CoV and MERS-CoV, and 30 nM for murine hepatitis virus in delayed brain tumor cells. In vitro experiments and animal model data indicate that remdesivir inhibits SARS-CoV, MERS-CoV, and Ebola virus by inhibiting RNA-dependent RNA polymerase (RdRp). In vitro cell experiments showed that the half effective concentration (EC50) of remdesivir for the new coronavirus was 0.77 μmol·L-1.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.